• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Vital Images returns to profitability

Article

Rebounding from the slowdown reported earlier this year (SCAN 2/25/04), Vital Images scored record total revenue for the second quarter of $8 million versus $7.5 million in the year-ago period, a 6% increase. In 2Q 2004, Vital Images reported net

Rebounding from the slowdown reported earlier this year (SCAN 2/25/04), Vital Images scored record total revenue for the second quarter of $8 million versus $7.5 million in the year-ago period, a 6% increase. In 2Q 2004, Vital Images reported net earnings of $95,000, or 1¢ per diluted share, which includes $327,000 in costs related to the amortization of intangible assets purchased in the HInnovation acquisition, which was completed in February. In the same period last year, the company recorded net income of $666,000, or 6¢ per diluted share.

The company claimed increasing market share through direct sales and its distribution partnership with Toshiba Medical. Orders are also coming in through a PACS distribution agreement with McKesson Information Solutions.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.